SPS
RCUS icon

Susquehanna Portfolio Strategies’s Arcus Biosciences RCUS Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.18M Hold
239,966
– – 0.08% 296
2025
Q4 		$5.72M Hold
239,966
– – 0.09% 291
2025
Q3 		$3.26M Sell
239,966
-8,000
-3% -$83.2K 0.05% 394
2025
Q2 		$2.02M Buy
+247,966
New +$2.12M 0.04% 370
2024
Q1 		– Sell
-34,432
Closed -$658K – 922
2023
Q4 		$658K Buy
+34,432
New +$550K 0.01% 703

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Susquehanna Portfolio Strategies's RCUS Position: Q1 2026 in Review

Susquehanna Portfolio Strategies held its Arcus Biosciences (RCUS) position steady in Q1 2026 at 239,966 shares worth $5.18M. The position accounts for 0.08% of the portfolio, ranked #296.

Susquehanna Portfolio Strategies first reported a position in RCUS in Q4 2023 and has held it in 5 quarters since. The position peaked at $5.72M in Q4 2025. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Susquehanna Portfolio Strategies held 239,966 shares of Arcus Biosciences worth $5.18M as of Q1 2026.
  • Susquehanna Portfolio Strategies left its Arcus Biosciences share count unchanged in Q1 2026.
  • Arcus Biosciences made up 0.08% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #296 holding.
  • Susquehanna Portfolio Strategies first reported a position in Arcus Biosciences in Q4 2023 and has held it in 5 quarters since.
  • Susquehanna Portfolio Strategies's Arcus Biosciences position peaked at $5.72M in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.